Oct 2026· Cancer Nexus· Vol 2· 0 citations· 149 references
TL;DR
An ecological framework is introduced to conceptualize tumor‐associated microbiota as dynamic communities shaped by niche organization, microbial interactions, and host ecosystem constraints, and proposes a novel integrative multi‐omics framework to decode the microecological and tumor interaction networks.
Abstract
The interplay between the microbiome and the tumor microenvironment has emerged as a cutting‐edge area in cancer research, revealing complex interactions that influence tumor initiation, progression, and therapeutic response. Recent advances in microbiome research have expanded our understanding of tumor‐associated microbial communities beyond individual microbial signatures, highlighting their roles in shaping tumor ecosystems through ecological interactions. The composition and spatial distribution of intratumoral microbiota, the molecular dialogues between microbes, tumor cells, and immune components, and the contributions of microbial communities to tumor development and metastasis are systematically reviewed. Furthermore, it examines how microbial communities modulate the efficacy of chemotherapy and immunotherapy, underscoring their impact on treatment outcomes. Moving beyond previous microbiome–cancer reviews that have primarily emphasized microbial composition, individual taxa, or specific molecular mechanisms, an ecological framework is introduced to conceptualize tumor‐associated microbiota as dynamic communities shaped by niche organization, microbial interactions, and host ecosystem constraints. The development of microbiome‐based precision diagnostic biomarkers and emerging therapeutic strategies, including probiotics and fecal microbiota transplantation, is further evaluated. Additionally, it proposes a novel integrative multi‐omics framework to decode the microecological and tumor interaction networks. By synthesizing recent advances, this work establishes an ecological perspective for understanding microbiome–tumor interactions and guiding future development of microbiome‐informed precision oncology strategies.
A review of emerging interactions between OV treatment and the microbiome discusses how microbiome-informed strategies may complement OV-based immunotherapy and highlights the scarcity of longitudinal intratumoral and clinical microbiome data.
Farrukhbek Khamidov, Oybek Jalolov, Uktam Ne'matov et al.· Seminars in Oncology· 0 citations
Microorganisms within tumors, also known as intratumoral microbiota, actively shape the tumor microenvironment (TME), influencing cancer progression and treatment response. Research has therefore expanded beyond the gut microbiota to intratumoral bacterial and fungal communities. Advances in low‐biomass sequencing, con...
Min-Hui Xu, Jie Yu, Ying Chen et al.· MedComm· 0 citations
The gut microbiome has emerged as an important regulator of cancer biology, influencing carcinogenesis, treatment response, and therapy-related toxicity. This narrative review synthesizes current evidence on the mechanistic roles of the gut microbiota in gastrointestinal (GI) cancers and evaluates emerging microbiome-b...
Cancers develop within a host ecosystem in which kinds of factors such as gut and tumor‐resident microbiota influence the tumor microenvironment (TME) and therapeutic response. High‐throughput sequencing has revealed the presence of low‐biomass bacteria, fungi, and viruses across diverse malignancies, establishing the...
Juan Lu, Meng-Juan Xuan, Liang Yu et al.· MedComm· 0 citations
Cancer remains a major global health challenge, and growing evidence indicates that the gut microbiota plays an important role in cancer initiation, progression, metastasis, and response to treatment through complex interactions with host signaling, metabolism, and immunity. This comprehensive narrative review discusse...
P. Negi, Arpita Upreti, Preeti Budhlakoti et al.· Frontiers in Molecular Biosc...· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense desmoplastic and immunosuppressive tumor microenvironment that limits immune surveillance and therapeutic delivery. Emerging evidence indicates that PDAC harbors low-biomass but biologically relevant intratumoral microbial communities. This review synt...
Shikhar Chohan, Pallavi Punhani, S. Zaheer et al.· Surgical and Experimental Pa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.